This article has been retracted: Aging has completed its investigation of this paper. We found overlap between several transwell assay images used for multiple figures and data published by different authors. Specifically, in Figure 2E, the motility image for A549 si-NC overlaps an image from [1]. In Figure 2F, the invasion image for A549 si-NC overlaps an image from [2]. In Figure 4E, the H460 agomir-NC image is a duplicate of an image from [3]. In Figure 6D, the motility image for A549 si-NC overlaps an image from [4]. In Figure 6E, the invasion image for H460 si-VPS9D1-AS1 + antagomir-523-3p overlaps an image from [5]. In Figure 7F, invasion panels for H460 si-NC and si-VPS9D1-AS1+pc-HMGA2 overlap panels from [6,7]. Finally, panels for A549 agomir-NC in Figure 4D and H460 si-VPS9D1-AS1+pcDNA3.1 in Figure 7F overlap panels from [8]. As a result, all of the listed authors agreed that the article should be retracted.

The Administration of the Shandong University, Guangxi Medical University and their respective affiliated hospitals was notified about the retraction by Aging Journal because of the improper use of multiple pictures included in this manuscript. The authors apologize for any inconvenience this retraction has caused for the scientific community.

References

  • 1. Wang X, Chen X, Tian Y, Jiang D, Song Y. Long Noncoding RNA RGMB-AS1 Acts as a microRNA-574 Sponge Thereby Enhancing the Aggressiveness of Gastric Cancer via HDAC4 Upregulation. Onco Targets Ther. 2020; 13:1691–704. https://doi.org/10.2147/OTT.S234144 [PubMed] (Retracted).
  • 2. Deng J, Zhang Q, Lu L, Fan C. Long Noncoding RNA DLGAP1-AS1 Promotes the Aggressive Behavior of Gastric Cancer by Acting as a ceRNA for microRNA-628-5p and Raising Astrocyte Elevated Gene 1 Expression. Cancer Manag Res. 2020; 12:2947–60. https://doi.org/10.2147/CMAR.S246166 [PubMed] (Retracted).
  • 3. Liu Z, Li Z, Xu B, Yao H, Qi S, Tai J. Long Noncoding RNA PRR34-AS1 Aggravates the Progression of Hepatocellular Carcinoma by Adsorbing microRNA-498 and Thereby Upregulating FOXO3. Cancer Manag Res. 2020; 12:10749–62. https://doi.org/10.2147/CMAR.S263619 [PubMed]
  • 4. Song H, Song J, Lu L, Li S. SNHG8 is upregulated in esophageal squamous cell carcinoma and directly sponges microRNA-411 to increase oncogenicity by upregulating KPNA2. Onco Targets Ther. 2019; 12:6991–7004. https://doi.org/10.2147/OTT.S214881 [PubMed] (Retracted).
  • 5. Situ J, Zhang H, Jin Z, Li K, Mao Y, Huang W. MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway. Onco Targets Ther. 2020; 13:4257–70. https://doi.org/10.2147/OTT.S250101 [PubMed] (Retracted).
  • 6. Gao H, Sun X, Wang H, Zheng Y. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer. Cell Cycle. 2020; 19:1186–99. https://doi.org/10.1080/15384101.2020.1749466 [PubMed] (Retracted).
  • 7. Bi S, Wang Y, Feng H, Li Q. Long noncoding RNA LINC00657 enhances the malignancy of pancreatic ductal adenocarcinoma by acting as a competing endogenous RNA on microRNA-433 to increase PAK4 expression. Cell Cycle. 2020; 19:801–16. https://doi.org/10.1080/15384101.2020.1731645 [PubMed] (Retracted).
  • 8. Li J, Fan S, Liu S, Yang G, Jin Q, Xiao Z. LncRNA NOP14-AS1 Promotes Tongue Squamous Cell Carcinoma Progression by Targeting MicroRNA-665/HMGB3 Axis. Cancer Manag Res. 2021; 13:2821–34. https://doi.org/10.2147/CMAR.S293322 [PubMed]